Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Asthma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Masking Description: No masking is used. All involved know the identity of the intervention assignment.Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 5 years and 11 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04673630
- Collaborators
- Amgen
- Investigators
- Principal Investigator: Jonathan Grigg, MD Royal London Hospital, United Kingdom